Zhejiang Conba Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Kang'enbei Pharmaceutical Co., Ltd., formerly known as Lanxi Yunshan Pharmaceutical Factory, has grown into the largest traditional Chinese medicine enterprise in the province (SH600572) that integrates drug research and development, production, and sales after more than 50 years of development. It is ranked among the top 50 Chinese pharmaceutical industries and top 10 Chinese traditional Chinese medicine enterprises, and has been selected as a state-owned enterprise "Science and Technology Reform Demonstration Enterprise" by the State Council. The controlling shareholder of the company is Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd. (a wholly-owned subsidiary of Zhejiang International Trade Group Co., Ltd.). The company is headquartered in Hangzhou, with Zhejiang as the industrial development center, and has established industrial bases in Jiangxi, Yunnan, Inner Mongolia and other provinces. The total number of employees exceeds 8000. The company has established national innovative enterprises, national enterprise technology centers, postdoctoral research workstations, academician workstations, provincial key laboratories for traditional Chinese medicine and pharmaceutical technology, and provincial key enterprise research institutes, as well as a large brand matrix represented by well-known Chinese trademarks such as Kang'enbei, Qianliekang, Tianbaoning, and well-known brands such as Jindi and Jinaokang. Since it was officially incorporated into the management system of Zhejiang International Trade Group in July 2020, the company has taken "inheriting the essence, keeping integrity and innovation" as the fundamental principle, focused on core business, innovative development and value improvement, and laid a good foundation for building the main platform of Zhejiang TCM health industry. In the future, the company will focus on the development goals of the life and health industry of the Provincial International Trade Group, fully leverage the advantages of the mixed reform system and mechanism, increase efforts in the field of traditional Chinese medicine health, and strive to achieve new breakthroughs in innovation platform construction, resource integration development, and management improvement and efficiency. In the new development ecology, the company will iterate its own competitiveness and become an important force in building a life and health science and technology innovation highland in our province, To contribute to the development of a strong province in traditional Chinese medicine and the construction of a demonstration zone for common prosperity through high-quality development. |
| Headquarter | Jinhua |
| Establish Date | 1/9/1993 |
| Listed Code | 600572.SH |
| Listed Date | 4/12/2004 |
| Chairman | Hu Jiqiang, Ying Chunxiao. |
| CEO | Luo Guoliang. |
| Website | www.conbapharm.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
